Bright Red funded Clinical Research Fellow Tom Creasey, Awarded Prize at Global Haematology Conference

Bright Red funded Clinical Research Fellow Tom Creasey, Awarded Prize at Global Haematology Conference

At the end of last year Bright Red funded Clinical Fellow Tom Creasey attended the 61st ASH Annual Meeting in Orlando, Florida. This is organised by the American Society of Haematology and is the largest Haematology conference in the world with over 25,000 attendees and presentations from over 4000 experts in all fields of Haematology.
Tom has been busy in the lab and the results of two pieces of his research into acute lymphoblastic leukaemia (ALL) were accepted for poster presentation at the conference.
In the first piece of work Tom looked at recurrent chromosomal abnormalities and copy number variations (when the number of copies of a particular gene varies from one individual to the next) in older adults with ALL.

In the second piece of work he used machine-learning techniques to develop a diagnostic classifier to identify a particular genetic subtype of ALL called low hypodiploid ALL. He has done this by looking at small changes in our DNA called Single Nucleotide Polymorphisms which differ in each person’s DNA.

You can read Tom’s full abstracts here:
https://doi.org/10.1182/blood-2019-124395

https://doi.org/10.1182/blood-2019-122556

You can also see some short video highlights from ASH 2019 here:
https://ecancer.org/en/conference/1128-ash-2019

No Comments

Sorry, the comment form is closed at this time.